ALFA Finder| Revenue growth | FY26 Consolidated: 5% YoY; Standalone: 4% YoY. |
|---|---|
| Margins | FY26 Consolidated EBITDA margin 8.1% vs 6.9% FY25. |
| Demand visibility | Softer export demand due to macroeconomic uncertainties. |
| Management confidence | Strong focus on 'China Plus One' strategy and import substitution. |
Growth
FY26 Consolidated Revenue grew 5% to ₹2,174 Cr; Standalone PAT rose 89% to ₹125.3 Cr.
Outlook
Commissioning 5,000 MTPA MPP plant for high-value insecticides; expansion in Nano Urea and Titanium Dioxide (TiO2) markets.
Risks
Macroeconomic uncertainties impacting export volumes; rising input costs and stable realisations pressuring margins.
Earnings Call filed with NSE, NSE: MOL. Summary written with AI assistance from the document.
Meghmani Organics Ltd: key numbers
- Share price
- ₹55.75
- Market cap
- ₹1,418 Cr
- Revenue (annual)
- ₹2,174 Cr
- Net profit (annual)
- ₹28.74 Cr
- P/E (TTM)
- 16.4×Sector 35.5×
- Promoter holding
- 48.95%+0.00% QoQ
- FII holding
- 0.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Meghmani Organics Ltd
All →Meghmani Organics Earnings Call Transcript: Key Takeaways
Consolidated Q2 net profit jumped 193% to ₹33.9 Cr off a weak base, but H1 revenue rose only 2% and standalone EBITDA was flat. Margin recovery depends on input costs normalising, which management hopes for but does not guide.
Meghmani Organics Results Update
MOL reported Q2 FY27 revenue of ₹658.2 crore, up 18% YoY, with net profit of ₹45.3 crore. EBITDA margin eased to 10.8% on elevated input costs.
Meghmani Organics Investor Presentation: Key Takeaways
Q2 FY27 standalone revenue ₹658.2 Cr (+18% YoY), EBITDA flat at ₹70.9 Cr, margin 10.8% under cost pressure; PAT ₹45.3 Cr (+6%). Strategy: TiO2 import substitution and nano fertiliser expansion.
Meghmani Organics Q2 FY27 Results: Net Profit ₹33.9 Cr, Up 192.2% YoY
Meghmani Organics Ltd reported revenue from operations of ₹666.9 Cr (+15.5% YoY) and net profit of ₹33.9 Cr (+192.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹33.9 Cr · +192.2% YoY
Meghmani Organics Credit Rating
India Ratings assigned Meghmani Organics' bank loan facilities of INR 11,000 million a rating of IND A/Stable/IND A1. The filing encloses the rating letter and a facilities breakup.
Meghmani Organics Board Meeting Date
Meghmani Organics will hold a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The meeting is a future notice, so no results are yet reported.